Social Network Intervention to Engage Community PLH to Engage in HIV Medical Care
1 other identifier
interventional
341
1 country
1
Brief Summary
People living with HIV infection (PLH) are clustered in friendship groups with other HIV+ persons, and an intervention delivered to all members of PLH social networks allows HIV+ people who are friends in day-to-day life to provide one another with support for entering, remaining, and adhering to HIV medical care. Moreover, an intervention delivered to groups attended by HIV+ persons who are friends increases HIV medical care engagement and decreases problem drinking more than individual counseling, probably because the network intervention harnessed mutual peer social support among friends who share the same HIV status, face similar coping issues, and interact together in day-to-day life. The planned research will be conducted in two phases in St. Petersburg, Russia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2017
CompletedFirst Posted
Study publicly available on registry
May 17, 2017
CompletedStudy Start
First participant enrolled
June 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedJanuary 14, 2026
February 1, 2023
5.1 years
May 9, 2017
January 12, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
HIV viral load values
Change in HIV viral load values at baseline will be compared with HIV viral load values determined at 6 months post-intervention and 12 months post-intervention.
0 months; 6 months; 12 months
HIV medical care visits
Change in the number of self-reported HIV medical care visits during the prior six months, comparing the number of visits reported at baseline to the number reported at six and twelve months at post-intervention followup assessments.
0 months; 6 months; 12 months
Antiretroviral medication adherence
Change in medication adherence during the past 30 days (as measured by the visual analogue scale; J.C. Walsh, et al, 2002), comparing the adherence percentage reported at baseline to the adherence percentage reported at the six and twelve month postintervention followup assessments.
0 months; 6 months; 12 months
Study Arms (2)
Social Network Endorsement
EXPERIMENTALAll participants in this arm will receive two intervention elements: (1) they will receive a brief single care-related counseling session and referral to HIV medical care upon enrollment; and (2) all members of the HIV+ social networks will attend a multi-session group intervention during which they will be trained to deliver messages endorsing compliance with medical guidelines and adherence to medical treatment regimens to friends. Additionally, these leaders will be trained how to deliver effective messages.
HIV Counseling and Referral to Care
ACTIVE COMPARATORAll study participants will receive a brief single care-related counseling session and referral to HIV medical care at baseline.
Interventions
Members of HIV+ social networks randomized to this arm will be trained to endorse compliance with medical guidelines and adherence to medical treatment regimens to their friends.
Members of HIV+ social networks randomized to this arm will attend a single, brief care-related counseling session and referral to care at baseline.
Eligibility Criteria
You may qualify if:
- Age 18 or older;
- Self-report as being HIV-positive, with positive HIV status confirmed in study-provided testing;
- Except for initial seeds, must be named by an already-enrolled participant as a PLH friend; and
- Do not plan to move from the St. Petersburg, Russia, area for the next 18 months.
You may not qualify if:
- Age 17 or younger;
- Self-report as HIV-negative or HIV-positive serostatus is not confirmed by testing;
- Not be named as a PLH friend by an already-enrolled participant; and
- Intend to move from the St. Petersburg, Russia, area during the next 18 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical College of Wisconsin
Milwaukee, Wisconsin, 53202, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yuri A. Amirkhanian, PhD
Medical College of Wisconsin
- PRINCIPAL INVESTIGATOR
Jeffrey A. Kelly, PhD
Medical College of Wisconsin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 9, 2017
First Posted
May 17, 2017
Study Start
June 8, 2017
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
January 14, 2026
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share